Your Messages Inbox
Your Article Summary
See Latest ArticlesA review on the treatment of relapsed/metastatic head and neck cancer
Expert Opinion in Pharmacotherapy, 10/05/09
Ferrari D et al. – The results of that trial seem to indicate a third agent added to CDDP and 5–FU improved both PFS and OS in the recurrent or metastatic setting. Unfortunately, the results obtained with the tyrosine kinase inhibitors are less impressive, and additional studies are needed to explore the potentiality of this class of drug.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Article Search
Sponsor